Huntington Disease
📧 Sign up to get email alerts when something new happens for Huntington Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-18FDA Approved: HALOPERIDOL — Original Application (Creekwood Pharmaceuticals LLC)
FDA approved Creekwood Pharmaceuticals' generic haloperidol under an original ANDA (ANDA 218162).
-
FDA approval · 2025-05-18FDA Approved: TETRABENAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for tetrabenazine, updating the approval/ labeling for this gene…
-
FDA approval · 2025-02-28FDA Approved: AUSTEDO XR — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for AUSTEDO XR (deutetrabenazine) from Teva Neuroscience, Inc. The action involves the extended-rele…
-
FDA approval · 2025-02-28FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for Austedo (deutetrabenazine) from Teva Neuroscience, Inc. The approval updates the labeling for th…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Haloperidol lactate from Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL submitted by Lannett Company, Inc., authorizing changes to the product's approva…
-
FDA approval · 2024-07-01FDA Approved: AUSTEDO XR — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved Teva's supplemental application for AUSTEDO XR (deutetrabenazine), an extended-release formulation of Austedo.
-
FDA approval · 2024-05-29FDA Approved: AUSTEDO XR — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for AUSTEDO XR (deutetrabenazine) by Teva Neuroscience, expanding the product to include an extended…
-
FDA approval · 2023-09-28FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for Austedo (deutetrabenazine) submitted by Teva Neuroscience, Inc. The approval updates the labelin…
-
FDA approval · 2023-05-19FDA Approved: TETRABENAZINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for tetrabenazine from Apotex Corp.
-
FDA approval · 2023-02-17FDA Approved: AUSTEDO XR — Original Application (Teva Neuroscience, Inc.)
FDA approved AUSTEDO XR (deutetrabenazine) from Teva Neuroscience in an original NDA; the extended-release formulation targets symptoms of H…
-
FDA approval · 2021-02-09FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for Austedo (deutetrabenazine) from Teva Neuroscience, Inc., indicating an approved update to th…
-
FDA approval · 2021-01-06FDA Approved: TETRABENAZINE — Supplemental Application (Precision Dose Inc.)
FDA has approved a supplemental application for tetrabenazine from Precision Dose Inc.
-
FDA approval · 2021-01-04FDA Approved: TETRABENAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for tetrabenazine filed by Sun Pharmaceutical Industries, Inc. This action expands the approved …
-
FDA approval · 2021-01-04FDA Approved: TETRABENAZINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for tetrabenazine from Camber Pharmaceuticals, Inc., enabling a generic version to be marketed. This…
-
FDA approval · 2020-12-04FDA Approved: TETRABENAZINE — Original Application (Ajanta Pharma USA Inc.)
FDA approved an Original Application for a generic tetrabenazine from Ajanta Pharma USA Inc.
-
FDA approval · 2020-12-02FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)
FDA approves a supplemental application for Austedo (deutetrabenazine) from Teva Neuroscience, Inc.
-
FDA approval · 2020-03-17FDA Approved: TETRABENAZINE — Original Application (Apotex Corp.)
FDA approved Apotex's generic tetrabenazine through an original application, expanding access to treatment for Huntington disease–related ch…
-
FDA approval · 2020-01-22FDA Approved: TETRABENAZINE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the original application for tetrabenazine from Slate Run Pharmaceuticals, LLC, enabling the marketing of a generic tetrabenazi…
-
FDA approval · 2019-07-01FDA Approved: HALOPERIDOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for haloperidol lactate (HALOPERIDOL LACTATE) as a generic injectable from Fresenius Kabi USA, LLC.
-
FDA approval · 2018-01-08FDA Approved: TETRABENAZINE — Original Application (Dr. Reddys Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' generic tetrabenazine (ANDA 209284) as an original application for Huntington's disease–related chore…
-
FDA approval · 2017-12-18FDA Approved: TETRABENAZINE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s original Abbreviated New Drug Application for tetrabenazine, a generic treatment for chorea associated with H…
-
FDA approval · 2017-09-13FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Xenazine (tetrabenazine) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2017-04-03FDA Approved: AUSTEDO — Original Application (Teva Neuroscience, Inc.)
FDA approved AUSTEDO (deutetrabenazine) in an original application for the treatment of chorea in Huntington's disease.
-
FDA approval · 2017-01-31FDA Approved: TETRABENAZINE — Original Application (Precision Dose Inc.)
FDA approved the original ANDA for tetrabenazine by Precision Dose Inc., enabling a generic version of the Huntington's disease chorea treat…